Effects of Different Dopaminergic Antagonists on Bromocriptine-Induced Inhibition of Norepinephrine Release*
- 1 July 1984
- journal article
- research article
- Published by The Endocrine Society in Journal of Clinical Endocrinology & Metabolism
- Vol. 59 (1) , 74-78
- https://doi.org/10.1210/jcem-59-1-74
Abstract
In this study we evaluated the effects of placebo or acute bromocriptine (BC) administration (2.5 mg orally) on plasma catecholamines, systolic and diastolic blood pressure (BP), heart rate, and plasma PRL in six normal subjects [group I, mean age 33.2 ± 5.4 (SD) yr] in the supine as well as upright position. BC induced a significant decrease in plasma norepinephrine in the supine [167.7 ± 16.8 (SEM) VS. 101.9 ± 33.7 pg/ml, P < 0.005] and upright positions [397.3 ± 27.7 vs. 211.3 ± 26.7 pg/ml, P < 0.005], a decrease in systolic and diastolic BP and a decrease in plasma PRL (P < 0.01). After standing, epinephrine levels increased significantly (53.6 ± 11.8 us. 226.4 ± 71.0 pg/ml, P < 0.05). The study was repeated in a second group of seven normal subjects (mean age, 32.3 ± 12.9 yr) after placebo or metoclopramide (20 mg orally) plus BC. In this group metoclopramide, a central and peripheral antidopaminergic agent, counteracted the BC-induced effects found in group I, both in the basal and stimulated conditions. Plasma PRL increased significantly (P < 0.025). Finally, to assess the effect of peripheral dopaminergic blockade on BC-induced changes in sympathetic outflow, we repeated the study in seven normal subjects (group III, mean age, 30.1 ± 5.0 yr) after placebo or domperidone (20 mg orally) plus BC. Domperidone blocked the effects of BC on norepinephrine and BP in the supine position. On standing there was a significant decrease in systolic (P < 0.05) and diastolic (P < 0.05) BP and an increase in epinephrine levels (58.9 ± 12.2 us. 109.8 ± 24.6 pg/ml, P < 0.05) was still observed. Plasma PRL increased significantly (P < 0.025). The results of this study suggest that the inhibition of sympathetic outflow induced by BC is peripherally mediated. As peripheral dopamine receptor blockade did not counteract all the effects after BC during standing, dopaminergic modulation of central reflex sympathetic activation is suggested.Keywords
This publication has 11 references indexed in Scilit:
- Failure of Bromocriptine to Lower Plasma Catecholamines in Normal Men and Women*Journal of Clinical Endocrinology & Metabolism, 1982
- Dopaminergic Control of Circadian Norepinephrine Levels in Patients with Essential HypertensionJournal of Clinical Endocrinology & Metabolism, 1981
- HEART-RATE LOWERING EFFECTS OF N,N-DI-N-PROPYL-DOPAMINE IN RATS - EVIDENCE FOR STIMULATION OF CENTRAL DOPAMINE-RECEPTORS LEADING TO INHIBITION OF SYMPATHETIC TONE AND ENHANCEMENT OF PARASYMPATHETIC OUTFLOW1981
- Dopaminergic Control of Plasma Catecholamine and Aldosterone Responses to Acute Stimuli in Normal ManJournal of Clinical Endocrinology & Metabolism, 1980
- Comparative assessment of stimuli that release neuronal and adrenomedullary catecholamines in man.Circulation, 1979
- Bromocriptine inhibits norepinephrine releaseClinical Pharmacology & Therapeutics, 1979
- Multiple receptors for dopamineNature, 1979
- Effects of pimozide on noradrenergic transmission in rabbit isolated ear arteriesEuropean Journal of Pharmacology, 1977
- Presynaptic receptor systems in catecholaminergic transmissionBiochemical Pharmacology, 1977
- INHIBITION OF SYMPATHETIC NERVOUS-SYSTEM BY 5,6-DIHYDROXY-2-DIMETHYLAMINO TETRALIN (M-7), APOMORPHINE AND DOPAMINE1975